ProShares Trust ProShares Ultra (SLON)

Key Updates

SLON declined an additional 2.12% to $17.98 on June 17, extending the post-peak deterioration from the June 15 high of $19.19 — a cumulative retracement of approximately 6.3% across two sessions. The pattern is consistent with the prior analysis: the June 15 spike (+26.30%) has failed to attract follow-through buying, and the fund continues to drift lower within a structurally impaired YTD trend. No new SLON-specific catalysts have emerged; the sole new article (June 17) relates to a Solana-based STO for a U.S. medical device business, which has no direct bearing on SLON's leveraged exposure mechanics.

Current Trend

The YTD trend remains deeply negative at -74.44%, with SLON having surrendered nearly three-quarters of its value since January 2026. The recent price action reflects a classic dead-cat bounce structure: a violent 5-day surge of +30.19% followed by immediate fading, with the fund unable to reclaim or sustain any meaningful resistance level. The 1-month return of -29.77% underscores that the intermediate trend is still firmly bearish, and the 2-session post-peak decline confirms that the June 15 rally was not a trend reversal. Key near-term reference points remain the June 15 intraday high of $19.19 (resistance) and the pre-bounce trough near $15.19 (support).

Investment Thesis

SLON is a leveraged ETF providing 2x daily exposure to Solana (SOL). Its investment thesis is entirely contingent on: (1) sustained directional appreciation in SOL price, (2) favorable conditions for leveraged crypto products including regulatory clarity and institutional adoption of Solana-based infrastructure, and (3) the compounding mechanics of a 2x daily reset product working in favor of investors during trending, low-volatility upside environments. The broader Solana ecosystem continues to attract institutional-grade development — tokenized real-world assets (Securitize's STAC expansion to Solana with a planned $250M Ethena Labs allocation), new DeFi infrastructure (Solayer's Margin Trade platform), and capital markets activity (First Block's Solana STO) — which in principle supports the underlying asset's long-term utility narrative.

Thesis Status

The bull thesis for SLON remains structurally intact at the ecosystem level but is not translating into price performance at the fund level. The 2x leverage mechanism has amplified SOL's drawdown catastrophically on a YTD basis, and the failure to hold gains from the June 15 spike signals that demand for the leveraged product itself remains weak. Ecosystem news (STAC, Solayer, STO announcements) is positive for Solana's long-term positioning but has not been sufficient to reverse the fund's price trend. The thesis is under significant stress; recovery requires both a sustained SOL rally and reduced volatility to prevent continued decay from daily rebalancing.

Key Drivers

The following developments are relevant to SLON's underlying exposure and ecosystem context:

• Institutional tokenization on Solana: Securitize's expansion of the STAC tokenized AAA CLO fund to Solana, with Ethena Labs planning a $250M allocation, signals growing institutional confidence in Solana's infrastructure for regulated financial products. — PR Newswire, June 12
• DeFi infrastructure expansion: Solayer's launch of Margin Trade — a Solana-native perpetual trading platform supporting crypto, commodities, and synthetic equities — adds transactional depth and utility to the Solana ecosystem, potentially increasing on-chain activity and SOL demand. — PR Newswire, May 28
• Capital markets activity: The first Solana-based STO for a U.S. medical device business (First Block/Onpharma/Crito Capital) represents incremental adoption of Solana for real-world securities issuance, broadening the ecosystem's use-case footprint. — Decrypt, June 17

Technical Analysis

SLON is trading at $17.98, below the June 15 resistance peak of $19.19 and above the June 14 trough of $15.19. The 2-session retracement following the +26.30% spike is consistent with a failed breakout pattern. The 5-day return of +30.19% is an artifact of the spike from deeply oversold levels and does not indicate a trend change. Immediate resistance is at $19.19 (June 15 high); immediate support is at $15.19 (pre-bounce low). A breach of $15.19 would re-expose the fund to the broader YTD downtrend with limited technical support visible below. The 1-month return of -29.77% confirms the intermediate trend remains bearish. Volatility remains extreme, consistent with a 2x leveraged crypto product in a downtrending underlying asset.

Bull Case

• 1. Institutional capital flowing into Solana infrastructure: Securitize's STAC fund expansion to Solana with a planned $250M allocation from Ethena Labs reflects high-conviction institutional commitment to Solana as a regulated financial infrastructure layer, which could structurally increase SOL demand and support a sustained price recovery that SLON would amplify 2x. — PR Newswire, June 12
• 2. Broadening real-world asset tokenization on Solana: The first U.S. medical device STO on Solana (First Block/Onpharma) demonstrates expanding use of Solana for regulated capital markets transactions, incrementally increasing the network's transaction volume and utility value. — Decrypt, June 17
• 3. Ecosystem depth expansion via DeFi infrastructure: Solayer's Margin Trade platform — developed by former Citadel and Kraken traders — introduces institutional-grade perpetual trading natively on Solana, increasing on-chain activity and potentially driving SOL demand through fee generation and collateral requirements. — PR Newswire, May 28
• 4. Extreme oversold YTD positioning creates mean-reversion potential: A -74.44% YTD decline positions SLON at levels where even a moderate SOL recovery would generate outsized returns due to 2x leverage, as evidenced by the +26.30% single-session surge on June 15 from the trough near $15.19. — Price data provided.
• 5. Global CLO market scale ($1.3T) validates institutional blockchain adoption: Securitize's STAC expansion into a $1.3 trillion CLO market on Solana demonstrates that the network is being selected for large-scale, high-grade institutional product deployment, lending credibility to Solana's long-term infrastructure role. — PR Newswire, June 12

Bear Case

• 1. Catastrophic YTD decay from 2x leverage compounding: SLON's -74.44% YTD decline demonstrates the severe impact of daily rebalancing decay in a volatile, downtrending environment — a structural characteristic of leveraged ETFs that permanently destroys NAV regardless of eventual SOL recovery, making full capital recovery mathematically improbable for current holders. — Price data provided.
• 2. Failed breakout confirms absence of sustained buying conviction: The June 15 spike of +26.30% has been followed by two consecutive sessions of decline (-4.27%, -2.12%), confirming that the bounce was not supported by durable demand and that the fund remains in a distribution phase below $19.19 resistance. — Price data provided.
• 3. Ecosystem news not translating to SOL price support: Despite multiple positive Solana ecosystem announcements (STAC, Solayer, STO), SLON continues to decline, indicating that these developments are either already priced in or insufficient to drive the sustained SOL price appreciation needed to benefit a 2x leveraged product. — PR Newswire, June 12; PR Newswire, May 28
• 4. Intermediate trend firmly bearish at -29.77% over 1 month: The 1-month return of -29.77% confirms that the intermediate trend remains negative even after accounting for the June 15 spike, with no evidence of a structural trend reversal in the underlying SOL price or the leveraged fund. — Price data provided.
• 5. Testnet-stage infrastructure limits near-term revenue impact: Solayer's Margin Trade platform is currently in public testnet, meaning its potential contribution to Solana on-chain activity and SOL demand is speculative and not yet reflected in actual network metrics or transaction volumes. — PR Newswire, May 28